INSERM, U912, SE4S, Marseille, Bouches-du-Rhône, France.
J Acquir Immune Defic Syndr. 2011 Jul 1;57 Suppl 1:S40-3. doi: 10.1097/QAI.0b013e318222b5c2.
Antiretroviral treatment (ART) scale-up in sub-Saharan Africa has made it possible to investigate the maintenance of adherence to HIV medications. We describe here adherence to ART and identify its correlates in the Cameroonian context.
Prospective cohort study in 9 rural district hospitals.
A mixed logistic regression model was used to identify factors associated with adherence to ART in 401 patients with data prospectively collected on adherence.
Although 73% of patients were adherent after the first month on ART, this proportion decreased to 61% after 24 months. After adjustment for known factors of adherence to ART (such as knowledge, motivation and side-effects), patients who reported willingness to start ART before initiation, those who were satisfied with information provided by their physicians, and those who implemented reminder methods for ART intake {eg, using an alarm clock, mobile phone, or watch [odds ratio (95% confidence interval)] = 2.45 (1.58 to 3.79), but also the help of a relative to remind them or other methods} were more likely to be adherent to ART.
Besides highlighting some correlates already known to have an impact on adherence to ART, our findings also underline the need to reinforce the counseling component of follow-up through innovative methods. Accordingly, training and implementation research should encourage the use of medication reminder methods, such as mobile phones, to assure adherence over time and improve long-term response to ART.
抗逆转录病毒治疗(ART)在撒哈拉以南非洲的推广使得研究 HIV 药物的坚持服用情况成为可能。我们在此描述了喀麦隆背景下的 ART 坚持服用情况,并确定了其相关因素。
9 家农村地区医院的前瞻性队列研究。
使用混合逻辑回归模型,根据前瞻性收集的关于坚持服用的数据,确定了 401 名患者坚持服用 ART 的相关因素。
尽管 73%的患者在开始 ART 治疗后的第一个月就坚持服用,但这一比例在 24 个月后降至 61%。在调整了已知的 ART 坚持因素(如知识、动机和副作用)后,那些在开始治疗前表示愿意开始 ART 的患者、对医生提供的信息感到满意的患者、以及采取提醒服用 ART 方法的患者(例如使用闹钟、手机或手表[比值比(95%置信区间)] = 2.45(1.58 至 3.79)),以及得到亲戚提醒或其他方法的患者),更有可能坚持服用 ART。
除了强调一些已知对 ART 坚持有影响的相关因素外,我们的研究结果还强调需要通过创新方法加强后续治疗中的咨询部分。因此,培训和实施研究应鼓励使用药物提醒方法,如手机,以确保随着时间的推移坚持服药,并提高对 ART 的长期反应。